Smart software aims to improve repeat heart ablation for AFib
NCT ID NCT05477147
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new approach for repeat catheter ablation in people with atrial fibrillation (AF) whose symptoms returned after a previous ablation. Doctors used a special software algorithm (VX1) to guide the procedure. The study included 96 adults and measured how many stayed free from AF episodes for one year after the repeat ablation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
catheter ablation guided by VX1 algorithm
What this could lead to
If successful, this approach could improve the success rate of repeat ablation procedures for atrial fibrillation, reducing the need for further treatments.
What could go wrong
This was a small, non-randomized study with no control group, so results may not be definitive. The procedure carries standard risks of catheter ablation, such as bleeding or heart rhythm issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allegheny Health Network
Pittsburgh, Pennsylvania, 15212, United States
-
Arrhythmia Research Group
Jonesboro, Arkansas, 72401, United States
-
Ascension St. Vincent's Hospital
Jacksonville, Florida, 32204, United States
-
Brigham and Women's Hospital
Boston, Massachusetts, 02241, United States
-
Clinique Pasteur
Toulouse, 31076, France
-
Deutsches Herzzentrum München
München, 80636, Germany
-
Grandview Medical Center
Birmingham, Alabama, 35243, United States
-
Houston Methodist Research Institute
Houston, Texas, 77030, United States
-
Hôpital Privé Jacques Cartier
Massy, 91300, France
-
Inova Fairfax Hospital
Fairfax, Virginia, 22042, United States
-
Kansas City Cardiac Arrhythmia Research LLC
Overland Park, Kansas, 66211, United States
-
Loyola University
Maywood, Illinois, 60152, United States
-
Northshore University Health System
Evanston, Illinois, 60201, United States
-
Northwell Health System
New York, New York, 11030, United States
-
Northwestern University
Evanston, Illinois, 60208, United States
-
OLV Aalst
Aalst, 9300, Belgium
-
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, 19104, United States
-
The Ohio State University
Columbus, Ohio, 43210, United States
-
Washington University
St Louis, Missouri, 63130, United States